Overexpression of ACE2 produces antitumor effects via inhibition of angiogenesis and tumor cell invasion in vivo and in vitro

Oncology Reports

Volumn 26, Issue 5, 2011, Pages 1157-1164

  Feng, Yun ^a   Ni, Lei ^a   Wan, Huanying ^a   Fan, Liang ^a   Fei, Xiaochun ^a   Ma, Qinyun ^a   Gao, Beili ^a   Xiang, Yi ^a   Che, Jiaming ^a   Li, Qingyun ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Angiotensin converting enzyme 2; Invasion; Matrix metalloproteinases; Non small cell lung cancer

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN CONVERTING ENZYME 2; GELATINASE A; GELATINASE B; VASCULOTROPIN A;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ARTICLE; CANCER INHIBITION; CANCER INVASION; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; ENZYME SYNTHESIS; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG NON SMALL CELL CANCER; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR XENOGRAFT; WESTERN BLOTTING;

ANIMALS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; DOWN-REGULATION; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; PEPTIDYL-DIPEPTIDASE A; SIGNAL TRANSDUCTION; TRANSDUCTION, GENETIC; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 80053137629     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2011.1394     Document Type: Article

References (40)

1. Erridge SC, Moller H, Price A and Brewster D: International comparisons of survival from lung cancer: pitfalls and warnings. Nat Clin Pract Oncol 4: 570-577, 2007. (Pubitemid 47534756)
2. McCracken M, Olsen M, Chen MS Jr, Jemal A, Thun M, Cokkinides V, Deapen D and Ward E: Cancer incidence, mortality, and associated risk factors among Asian Americans of Chinese, Filipino, Vietnamese, Korean, and Japanese ethnicities. CA Cancer J Clin 57: 190-205, 2007. (Pubitemid 47312080)
3. Shivapurkar N, Reddy J, Chaudhary PM and Gazdar AF: Apoptosis and lung cancer: a review. J Cell Biochem 88: 885-898, 2003. (Pubitemid 36337033)
4. Brunner HR, Laragh JH, Baer L, Newton MA, Goodwin FT, Krakoff LR, Bard RH and Buhler FR: Essential hypertension: renin and aldosterone, heart attack and stroke. N Engl J Med 286: 441-449, 1972.
5. Fleming I, Kohlstedt K and Busse R: The tissue renin-angiotensin system and intracellular signalling. Curr Opin Nephrol Hypertens 15: 8-13, 2006.
6. Santos RA, Campagnole-Santos MJ and Andrade SP: Angiotensin-(1-7): an update. Regul Pept 91: 45-62, 2009.
7. Huang SC, Ho CT, Lin-Shiau SY and Lin JK: Carnosol inhibits the invasion of B16/F10 mouse melanoma cells by suppressing metalloproteinase- 9 through down-regulating nuclear factor-kappa B and c-Jun. Biochem Pharmacol 69: 221-232, 2005.
8. Mook OR, Frederiks WM and Van Noorden CJ: The role of gelatinases in colorectal cancer progression and metastasis. Biochim Biophys Acta 1705: 69-89, 2004. (Pubitemid 39592897)
9. Ino K, Shibata K, Kajiyama H, Nawa A, Nomura S and Kikkawa F: Manipulating the angiotensin system - new approaches to the treatment of solid tumours. Expert Opin Biol Ther 6: 243-255, 2006. (Pubitemid 43344744)
10. Vinson GP, Ho MM and Puddefoot JR: The distribution of angiotensin II type 1 receptors, and the tissue renin-angiotensin systems. Mol Med Today 1: 35-39, 2005.
11. Taylor GM, Cook HT, Sheffield EA, Hanson C and Peart WS: Renin in blood vessels in human pulmonary tumors. An immunohistochemical and biochemical study. Am J Pathol 130: 543-551, 1988. (Pubitemid 18091383)
12. Attoub S, Gaben AM, Al-Salam S, Al Sultan MA, John A, Nicholls MG, Mester J and Petroianu G: Captopril as a potential inhibitor of lung tumor growth and metastasis. Ann NY Acad Sci 1138: 65-72, 2008.
13. Imai N, Hashimoto T, Kihara M, Yoshida S, Kawana I, Yazawa T, Kitamura H and Umemura S: Roles for host and tumor angiotensin II type 1 receptor in tumor growth and tumor-associated angiogenesis. Lab Invest 87: 189-198, 2007.
14. Prontera C, Mariani B, Rossi C, Poggi A and Rotilio D: Inhibition of gelatinase A (MMP-2) by batimastat and captopril reduces tumor growth and lung metastases in mice bearing Lewis lung carcinoma. Int J Cancer 81: 761-766, 1999. (Pubitemid 29214387)
15. Gallagher PE and Tallant EA: Inhibition of human lung cancer cell growth by angiotensin-(1-7). Carcinogenesis 25: 2045-2052, 2004. (Pubitemid 39534840)
16. Soto-Pantoja DR, Menon J, Gallagher PE and Tallant EA: Angiotensin-(1-7) inhibits tumor angiogenesis in human lung cancer xenografts with a reduction in vascular endothelial growth factor. Mol Cancer Ther 8: 1676-1683, 2009.
17. Zisman LS, Keller RS, Weaver B, Lin Q, Speth R, Bristow MR and Canver CC: Increased angiotensin-(1-7)-forming activity in failing human heart ventricles: evidence for upregulation of the angiotensin-converting enzyme homologue ACE2. Circulation 108: 1707-1712, 2003. (Pubitemid 37243658)
18. Li N, Zimpelmann J, Cheng K, Wilkins JA and Burns KD: The role of angiotensin-converting enzyme 2 in the generation of angiotensin 1-7 by rat proximal tubules. Am J Physiol Renal Physiol 288: F353-F362, 2005. (Pubitemid 40105394)
19. Campbell DJ, Zeitz CJ, Esler MD and Horowitz JD: Evidence against a major role for angiotensin converting enzyme-related carboxypeptidase (ACE2) in angiotensin peptide metabolism in the human coronary circulation. J Hypertens 22: 1971-1976, 2004. (Pubitemid 39336680)
20. Feng Y, Wan H, Liu J, Zhang R, Ma Q, Han B, Xiang Y, Che J, Cao H, Fei X and Qiu W: The angiotensin-converting enzyme 2 in tumor growth and tumor-associated angiogenesis in non-small cell lung cancer. Oncol Rep 23: 941-948, 2010.
21. Guo RW, Yang LX, Wang H, Liu B and Wang L: Angiotensin II induces matrix metalloproteinase-9 expression via a nuclear factor-kappaB-dependent pathway in vascular smooth muscle cells. Regul Pept 147: 37-44, 2008.
22. Okada M, Kosaka N, Hoshino Y, Yamawaki H and Hara Y: Effects of captopril and telmisartan on matrix metalloproteinase- 2 and -9 expressions and development of left ventricular fibrosis induced by isoprenaline in rats. Biol Pharm Bull 33: 1517-1521, 2010.
23. Yang LX, Liu H, Guo RW, Ye J, Wang XM, Qi F, Guo CM and Liang X: Angiotensin II induces EMMPRIN expression in THP-1 macrophages via the NF-kappaB pathway. Regul Pept 163: 88-95, 2010.
24. Zhou L, Xue H, Yuan P, Ni J, Yu C, Huang Y and Lu LM: Angiotensin AT1 receptor activation mediates high glucose-induced epithelial-mesenchymal transition in renal proximal tubular cells. Clin Exp Pharmacol Physiol 37: e152-e157, 2010.
25. Ishimatsu S, Itakura A, Okada M, Kotani T, Iwase A, Kajiyama H, Ino K and Kikkawa F: Angiotensin II augmented migration and invasion of choriocarcinoma cells involves PI3K activation through the AT1 receptor. Placenta 27: 587-591, 2006.
26. Huang W, Yu LF, Zhong J, Qiao MM, Jiang FX, Du F, Tian XL and Wu YL: Angiotensin II type 1 receptor expression in human gastric cancer and induces MMP2 and MMP9 expression in MKN-28 cells. Dig Dis Sci 53: 163-168, 2008. (Pubitemid 350265665)
27. Huang W, Yu LF, Zhong J, Wu W, Zhu JY, Jiang FX and Wu YL: Stat3 is involved in angiotensin II-induced expression of MMP2 in gastric cancer cells. Dig Dis Sci 54: 2056-2062, 2009.
28. Turner AJ, Tipnis SR, Guy JL, Rice G and Hooper NM: ACEH/ACE2 is a novel mammalian metallocarboxypeptidase and a homologue of angiotensin-converting enzyme insensitive to ACE inhibitors. Can J Physiol Pharmacol 80: 346-353, 2002. (Pubitemid 34451252)
29. Gembardt F, Sterner-Kock A, Imboden H, Spalteholz M, Reibitz F, Schultheiss HP, Siems WE and Walther T: Organ-specific distribution of ACE2 mRNA and correlating peptidase activity in rodents. Peptides 26: 1270-1277, 2005. (Pubitemid 40798085)
30. Donoghue M, Hsieh F, Baronas E, Godbout K, Gosselin M, Stagliano N, Donovan M, Woolf B, Robison K, Jeyaseelan R, Breitbart RE and Acton S: A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res 87: E1-E9, 2000.
31. Tipnis SR, Hooper NM, Hyde R, Karran E, Christie G and Turner AJ: A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem 275: 33238-33243, 2000.
32. Hamming I, Timens W, Bulthuis ML, Lely AT, Navis GJ and Van Goor H: Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol 203: 631-637, 2004. (Pubitemid 38714099)
33. Ren X, Glende J, Al-Falah M, De Vries V, Schwegmann-Wessels C, Qu X, Tan L, Tschernig T, Deng H, Naim HY and Herrler G: Analysis of ACE2 in polarized epithelial cells: surface expression and function as receptor for severe acute respiratory syndrome-associated coronavirus. J Gen Virol 87: 1691-1695, 2006. (Pubitemid 43827224)
34. Offersen BV, Borre M and Overgaard J: Quantification of angiogenesis as a prognostic marker in human carcinomas: a critical evaluation of histopathological methods for estimation of vascular density. Eur J Cancer 39: 881-890, 2003. (Pubitemid 36428619)
35. Carl-McGrath S, Ebert MP, Lendeckel U and Rocken C: Expression of the local angiotensin II system in gastric cancer may facilitate lymphatic invasion and nodal spread. Cancer Biol Ther 6: 1218-1226, 2007.
36. Wang L, Cai SR, Zhang CH, He YL, Zhan WH, Wu H and Peng JJ: Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor blockers on lymphangiogenesis of gastric cancer in a nude mouse model. Chin Med J (Engl) 121: 2167-2171, 2008.
37. Nakagawa T, Kubota T, Kabuto M and Kodera T: Captopril inhibits glioma cell invasion in vitro: involvement of matrix metalloproteinases. Anticancer Res 15: 1985-1989, 1995. (Pubitemid 26031270)
38. Rothhammer T, Hahne JC, Florin A, Poser I, Soncin F, Wernert N and Bosserhoff AK: The Ets-1 transcription factor is involved in the development and invasion of malignant melanoma. Cell Mol Life Sci 61: 118-128, 2004. (Pubitemid 38121905)
39. Sliva D: Signaling pathways responsible for cancer cell invasion as targets for cancer therapy. Curr Cancer Drug Targets 4: 327-336, 2004.
40. Kim D, Kim S, Koh H, Yoon SO, Chung AS, Cho KS and Chung J: Akt/PKB promotes cancer cell invasion via increased motility and metalloproteinase production. FASEB J 15: 1953-1962, 2001. (Pubitemid 32848799)